İbrahim Barış

In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials

Şeref Gül, Onur Özcan, Sinan Aşar et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 69 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Novel Missense Mutation in Human TTF-2 (FKHL15) Gene Associated with Congenital Hypothyroidism But Not Athyreosis

İbrahim Barış, Ayşe Engin Arısoy, Aaron G. Smith et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 67 citations · Full text

Medicine, Endocrinology, Genetics +17

Investigation of the Interaction between the Large and Small Subunits of Potato ADP-Glucose Pyrophosphorylase

İbrahim Barış, Aytug Tuncel, Natali Özber et al. · PLoS Computational Biology · 2009 · 36 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Frequency of the 35delG mutation in the connexin 26 gene in Turkish hearing‐impaired patients

İbrahim Barış, MO Kılınç, Aslıhan Tolun · Clinical Genetics · 2001 · 30 citations

Life Sciences, Genetics, Molecular Genetics +14

In Silico Identification of Widely Used and Well Tolerated Drugs That May Inhibit SARSCov- 2 3C-like Protease and Viral RNA-Dependent RNA Polymerase Activities, and May Have Potential to Be Directly Used in Clinical Trials

Şeref Gül, Onur Özcan, sinan asar et al. · ChemRxiv · 2020 · 11 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17